The emergence of precision urologic oncology: a collaborative review on biomarker-driven therapeutics

More about Open Access at the Crick

Authors list

Christopher E Barbieri Arul M Chinnaiyan Seth P Lerner Charles Swanton Mark A Rubin
Scroll for detail on labs, facilities & authors

Abstract

Biomarker-driven cancer therapy, also referred to as precision oncology, has received increasing attention for its promise of improving patient outcomes by defining subsets of patients more likely to respond to various therapies.

Journal details

Journal European Urology
Volume 71
Issue number 2
Pages 237-246
Publication date

Full text links

Publisher website (DOI) 10.1016/j.eururo.2016.08.024
Europe PubMed Central 27567210
Pubmed 27567210

Keywords

Related topics
Type of publication

Related content